418 related articles for article (PubMed ID: 25650440)
21. Simplet/Fam53b is required for Wnt signal transduction by regulating β-catenin nuclear localization.
Kizil C; Küchler B; Yan JJ; Özhan G; Moro E; Argenton F; Brand M; Weidinger G; Antos CL
Development; 2014 Sep; 141(18):3529-39. PubMed ID: 25183871
[TBL] [Abstract][Full Text] [Related]
22. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
Meng H; Zhao B; Wang Y
Exp Mol Pathol; 2020 Aug; 115():104451. PubMed ID: 32417392
[TBL] [Abstract][Full Text] [Related]
23. A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis.
Fang L; Zhu Q; Neuenschwander M; Specker E; Wulf-Goldenberg A; Weis WI; von Kries JP; Birchmeier W
Cancer Res; 2016 Feb; 76(4):891-901. PubMed ID: 26645562
[TBL] [Abstract][Full Text] [Related]
24. FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma.
Yu B; Zhou X; Li B; Xiao X; Yan S; Shi D
Ann Hematol; 2011 Jun; 90(6):701-8. PubMed ID: 21120478
[TBL] [Abstract][Full Text] [Related]
25. FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control.
Goatly A; Bacon CM; Nakamura S; Ye H; Kim I; Brown PJ; Ruskoné-Fourmestraux A; Cervera P; Streubel B; Banham AH; Du MQ
Mod Pathol; 2008 Jul; 21(7):902-11. PubMed ID: 18487996
[TBL] [Abstract][Full Text] [Related]
26. N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells.
Brown PJ; Gascoyne DM; Lyne L; Spearman H; Felce SL; McFadden N; Chakravarty P; Barrans S; Lynham S; Calado DP; Ward M; Banham AH
Haematologica; 2016 Jul; 101(7):861-71. PubMed ID: 27056922
[TBL] [Abstract][Full Text] [Related]
27. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
[TBL] [Abstract][Full Text] [Related]
28. A circular RNA from
Hu Y; Zhao Y; Shi C; Ren P; Wei B; Guo Y; Ma J
Aging (Albany NY); 2019 Oct; 11(19):8068-8084. PubMed ID: 31631067
[TBL] [Abstract][Full Text] [Related]
29. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations.
Wlodarska I; Veyt E; De Paepe P; Vandenberghe P; Nooijen P; Theate I; Michaux L; Sagaert X; Marynen P; Hagemeijer A; De Wolf-Peeters C
Leukemia; 2005 Aug; 19(8):1299-305. PubMed ID: 15944719
[TBL] [Abstract][Full Text] [Related]
30. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.
Ono M; Yin P; Navarro A; Moravek MB; Coon JS; Druschitz SA; Serna VA; Qiang W; Brooks DC; Malpani SS; Ma J; Ercan CM; Mittal N; Monsivais D; Dyson MT; Yemelyanov A; Maruyama T; Chakravarti D; Kim JJ; Kurita T; Gottardi CJ; Bulun SE
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17053-8. PubMed ID: 24082114
[TBL] [Abstract][Full Text] [Related]
31. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
[TBL] [Abstract][Full Text] [Related]
32. LGR6 activates the Wnt/β-catenin signaling pathway and forms a β-catenin/TCF7L2/LGR6 feedback loop in LGR6
Feng Q; Li S; Ma HM; Yang WT; Zheng PS
Oncogene; 2021 Oct; 40(42):6103-6114. PubMed ID: 34489551
[TBL] [Abstract][Full Text] [Related]
33. FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling.
Xing X; Liu M; Wang X; Guo Q; Wang H; Wang W
J Cell Mol Med; 2024 Jan; 28(1):e18041. PubMed ID: 37987202
[TBL] [Abstract][Full Text] [Related]
34. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
35. Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.
Brown PJ; Ashe SL; Leich E; Burek C; Barrans S; Fenton JA; Jack AS; Pulford K; Rosenwald A; Banham AH
Blood; 2008 Mar; 111(5):2816-24. PubMed ID: 18077790
[TBL] [Abstract][Full Text] [Related]
36. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.
Banham AH; Connors JM; Brown PJ; Cordell JL; Ott G; Sreenivasan G; Farinha P; Horsman DE; Gascoyne RD
Clin Cancer Res; 2005 Feb; 11(3):1065-72. PubMed ID: 15709173
[TBL] [Abstract][Full Text] [Related]
37. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
[TBL] [Abstract][Full Text] [Related]
38. Zfp703 Is a Wnt/β-Catenin Feedback Suppressor Targeting the β-Catenin/Tcf1 Complex.
Kumar A; Chalamalasetty RB; Kennedy MW; Thomas S; Inala SN; Garriock RJ; Yamaguchi TP
Mol Cell Biol; 2016 Jun; 36(12):1793-802. PubMed ID: 27090637
[TBL] [Abstract][Full Text] [Related]
39. Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1.
Rouhigharabaei L; Finalet Ferreiro J; Tousseyn T; van der Krogt JA; Put N; Haralambieva E; Graux C; Maes B; Vicente C; Vandenberghe P; Cools J; Wlodarska I
PLoS One; 2014; 9(1):e85851. PubMed ID: 24416450
[TBL] [Abstract][Full Text] [Related]
40. FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type.
Espinet B; García-Herrera A; Gallardo F; Baró C; Salgado R; Servitje O; Estrach T; Colomo L; Romagosa V; Barranco C; Serrano S; Campo E; Pujol RM; Solé F
Histol Histopathol; 2011 Feb; 26(2):213-21. PubMed ID: 21154235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]